Join the 'Lysteda' group to help and get support from people like you.
Posted 6 Sep 2016 by Drugs.com
TUESDAY, Sept. 6, 2016 – A simple salt-based spray is as effective as medicated sprays in controlling chronic nosebleeds, a new study contends. "This research highlights that there could be a benefit even in the simplest of interventions," said corresponding study author Dr. Kevin Whitehead. He is an associate professor of internal medicine at the University of Utah School of Medicine. People with a condition called hemorrhagic telangiectasia (HHT) are plagued with nosebleeds. Many have one nosebleed a week, and some have more than two a day. The new study included 121 people with the condition who sprayed either a saline solution (salt plus water) or one of three medications – bevacizumab, estriol or tranexamic acid – into their nose twice a day for 12 weeks. The saline spray was as effective in reducing nosebleeds as the drugs, according to the study. "No drug proved to be any ... Read more
Related support groups: Bleeding Disorder, Avastin, Tranexamic Acid, Lysteda, Cyklokapron, Bevacizumab, Rhinaris, Ayr Saline Nasal, ENTsol, Saline Nasal Mist, Simply Saline, Altamist, Little Noses, Humist, Neilmed Nasogel, Ocean, Ocean Kids, Sea Soft, Pediamist, Afrin Saline
Posted 9 Jan 2013 by Drugs.com
WEDNESDAY, Jan. 9 – Women with heavy menstrual bleeding may find some relief using an intrauterine device, or IUD, containing the hormone levonorgestrel, according to new research. British researchers found that the treated IUD was more effective at reducing the effects of heavy menstrual bleeding (also called menorrhagia) on quality of life compared to other treatments. Normally used for contraception, the intrauterine system is sold under the brand name Mirena. "If women suffer with heavy periods and do not want to get pregnant – as the levonorgestrel intrauterine system is a contraceptive – then having the levonorgestrel intrauterine system is a very good first-line treatment option that does not require taking regular, daily oral medications," said the study's lead author, Dr. Janesh Gupta, professor of obstetrics and gynecology at the University of Birmingham and Birmingham ... Read more